Polish Man Arrested for Illegal Possession and Sale of E-cigarettes

Oct.15.2024
Polish Man Arrested for Illegal Possession and Sale of E-cigarettes
A 22-year-old Polish man was arrested for illegal possession and sale of e-cigarettes in Milanowek, Poland.

According to Dziennik Wschodni on October 15th, a 22-year-old man from Poland was arrested by police for allegedly illegally possessing and selling e-cigarettes.


The man was stopped for a road check in Milan, where police noticed his unusually nervous behavior, raising suspicion. Upon further inspection, a large quantity of e-cigarettes without Polish tax stamps was found in his car.


Local police spokesperson Ewelina Semeniuk stated that the man claimed he purchased the e-cigarettes at a discounted price and had planned to sell them for profit. He has been detained by authorities.


Subsequently, police went to the warehouse he rented in Biarlski County, ultimately seizing over 3,000 illegal e-cigarettes. The man has been charged and will soon face trial in court.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21
EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.
Dec.10 by 2FIRSTS.ai
WHO MOP4 Focuses on Justice and Prosecution to Combat Illicit Tobacco Trade
WHO MOP4 Focuses on Justice and Prosecution to Combat Illicit Tobacco Trade
The Fourth Meeting of the Parties (MOP4) to the Protocol to Eliminate Illicit Trade in Tobacco Products opened in Geneva on November 24, 2025. With 60 Parties participating, the meeting focuses on strengthening legal action and international cooperation to combat illicit trade, which accounts for about 11% of the global tobacco market and costs governments billions in lost tax revenue.
Nov.25 by 2FIRSTS.ai
Wisconsin Lawmakers Revive Bill to Raise Legal Age for Tobacco and Vaping Purchases to 21
Wisconsin Lawmakers Revive Bill to Raise Legal Age for Tobacco and Vaping Purchases to 21
Wisconsin Senate Bill 524 (SB 524) has been reintroduced to raise the legal purchasing age for tobacco and electronic nicotine products from 18 to 21, aiming to eliminate the gap between state law and the federal “Tobacco 21” standard. Some retailers in Madison have already voluntarily adopted the 21-year age limit, while the American Lung Association is urging swift legislative action.
Dec.04 by 2FIRSTS.ai
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
Latvia’s Constitutional Court Upholds Vape Flavor Ban as Constitutional
The Constitutional Court of Latvia upheld the 2025 vape-flavor ban as constitutional, rejecting appeals by Pro Vape and SIA MASS Industry. Judges said the restrictions serve a legitimate public-health purpose by protecting youth from nicotine addiction and that the social benefits outweigh business losses.
Oct.24 by 2FIRSTS.ai
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
Trump Signs H.R.5371: FDA to Deploy $200 Million for ENDS Enforcement
President Donald Trump signed the Continuing Appropriations Act, 2026 (H.R.5371) on November 12, Section 772 of Part B—the Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act (S.2256)—requires the FDA to allocate no less than $200 million in tobacco user fees to enforce regulations against illegal e-cigarettes, vapes, and other ENDS products. At least $2 million of this funding supports a federal multi-agency task force targeting products originating from the China.
Nov.14 by 2FIRSTS.ai